COHBAR INC (CWBR) Fundamental Analysis & Valuation

NASDAQ:CWBR • US19249J3077

Current stock price

0.761 USD
-0.14 (-15.44%)
At close:
0.7345 USD
-0.03 (-3.48%)
After Hours:

This CWBR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. CWBR Profitability Analysis

1.1 Basic Checks

  • CWBR had negative earnings in the past year.
  • In the past year CWBR has reported a negative cash flow from operations.
CWBR Yearly Net Income VS EBIT VS OCF VS FCFCWBR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 -5M -10M -15M

1.2 Ratios

  • With a Return On Assets value of -101.44%, CWBR is not doing good in the industry: 79.57% of the companies in the same industry are doing better.
  • CWBR has a worse Return On Equity (-133.58%) than 64.45% of its industry peers.
Industry RankSector Rank
ROA -101.44%
ROE -133.58%
ROIC N/A
ROA(3y)-68.44%
ROA(5y)-73.98%
ROE(3y)-75.95%
ROE(5y)-95.1%
ROIC(3y)N/A
ROIC(5y)N/A
CWBR Yearly ROA, ROE, ROICCWBR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 -50 -100 -150

1.3 Margins

  • CWBR does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CWBR Yearly Profit, Operating, Gross MarginsCWBR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. CWBR Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for CWBR has been increased compared to 1 year ago.
  • CWBR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CWBR Yearly Shares OutstandingCWBR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 500K 1M 1.5M 2M 2.5M
CWBR Yearly Total Debt VS Total AssetsCWBR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M 25M

2.2 Solvency

  • Based on the Altman-Z score of -13.68, we must say that CWBR is in the distress zone and has some risk of bankruptcy.
  • CWBR's Altman-Z score of -13.68 is on the low side compared to the rest of the industry. CWBR is outperformed by 84.22% of its industry peers.
  • CWBR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -13.68
ROIC/WACCN/A
WACCN/A
CWBR Yearly LT Debt VS Equity VS FCFCWBR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 10M -10M 20M

2.3 Liquidity

  • CWBR has a Current Ratio of 4.16. This indicates that CWBR is financially healthy and has no problem in meeting its short term obligations.
  • CWBR has a Current ratio (4.16) which is in line with its industry peers.
  • CWBR has a Quick Ratio of 4.16. This indicates that CWBR is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 4.16, CWBR is in line with its industry, outperforming 43.52% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.16
Quick Ratio 4.16
CWBR Yearly Current Assets VS Current LiabilitesCWBR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M 25M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. CWBR Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 8.02% over the past year.
EPS 1Y (TTM)8.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-58.51%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-3.7%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CWBR Yearly EPS VS EstimatesCWBR Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 -2 -4 -6 -8

More info and screens

Find the best growth stocksShow best growing peers

0

4. CWBR Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CWBR. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CWBR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CWBR Price Earnings VS Forward Price EarningsCWBR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CWBR Per share dataCWBR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 -4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CWBR Dividend Analysis

5.1 Amount

  • CWBR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

CWBR Fundamentals: All Metrics, Ratios and Statistics

COHBAR INC

NASDAQ:CWBR (11/28/2023, 8:00:00 PM)

After market: 0.7345 -0.03 (-3.48%)

0.761

-0.14 (-15.44%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-14
Earnings (Next)03-07
Inst Owners6.24%
Inst Owner Change0%
Ins Owners238.68%
Ins Owner Change0%
Market Cap2.21M
Revenue(TTM)N/A
Net Income(TTM)-12.69M
Analysts43.33
Price Target18.36 (2312.61%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.23
P/tB 0.23
EV/EBITDA N/A
EPS(TTM)-4.36
EYN/A
EPS(NY)-4
Fwd EYN/A
FCF(TTM)-2.73
FCFYN/A
OCF(TTM)-2.73
OCFYN/A
SpS0
BVpS3.27
TBVpS3.26
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -101.44%
ROE -133.58%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-68.44%
ROA(5y)-73.98%
ROE(3y)-75.95%
ROE(5y)-95.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.16
Quick Ratio 4.16
Altman-Z -13.68
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)8.63%
Cap/Depr(5y)130.18%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)8.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-58.51%
EPS Next Y-3.7%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-7.72%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y41.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y40.94%
OCF growth 3YN/A
OCF growth 5YN/A

COHBAR INC / CWBR Fundamental Analysis FAQ

What is the fundamental rating for CWBR stock?

ChartMill assigns a fundamental rating of 2 / 10 to CWBR.


Can you provide the valuation status for COHBAR INC?

ChartMill assigns a valuation rating of 0 / 10 to COHBAR INC (CWBR). This can be considered as Overvalued.


Can you provide the profitability details for COHBAR INC?

COHBAR INC (CWBR) has a profitability rating of 0 / 10.


How financially healthy is COHBAR INC?

The financial health rating of COHBAR INC (CWBR) is 6 / 10.